Status
Conditions
Treatments
About
This study is to determine the following information.
Full description
This survey aims to determine the following information and the need for conducting specified drug use-results surveys and post-marketing clinical studies in patients using Betanis (generic name: mirabegron):
Items of Particular Interest:
Enrollment
Sex
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:
10,711 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal